Nucor vs DuPont

This page compares Nucor and DuPont, examining their business models, financial performance, and market context to provide a clear, neutral overview of how they operate in different sectors. It presents information about their strategies and market positions without offering guidance. Educational content, not financial advice.

This page compares Nucor and DuPont, examining their business models, financial performance, and market context to provide a clear, neutral overview of how they operate in different sectors. It presen...

Comparison Snapshot

Key Financial Metrics

NUE

Metric

DD

$40.66B

Market Cap

$18.52B

2.90%

Potential Profit

10.29%

Buy

Analyst Rating

Buy

Why It's Moving

Nucor Stock Dips Ahead of Pivotal Earnings Reveal as Options Heat Up.

Upcoming earnings on Jan. 26 project $1.91 EPS, a 56.6% year-over-year jump, with revenue eyed at $7.77B up 9.8%, testing if recent beats like Q3's $2.63 EPS can continue.
Mixed institutional moves: National Wealth Management grabbed a fresh $753K stake, but Harvey Capital slashed its position by 38% via 7,750 share sale, reflecting divergent investor bets.
Analysts lean bullish with 'Moderate Buy' consensus and $177 average target, fueled by strong liquidity (current ratio 2.77) and recent dividend hike payable Feb. 11.

Sentiment:

🌋Volatile

Nucor Stock Dips Ahead of Pivotal Earnings Reveal as Options Heat Up.

Upcoming earnings on Jan. 26 project $1.91 EPS, a 56.6% year-over-year jump, with revenue eyed at $7.77B up 9.8%, testing if recent beats like Q3's $2.63 EPS can continue.
Mixed institutional moves: National Wealth Management grabbed a fresh $753K stake, but Harvey Capital slashed its position by 38% via 7,750 share sale, reflecting divergent investor bets.
Analysts lean bullish with 'Moderate Buy' consensus and $177 average target, fueled by strong liquidity (current ratio 2.77) and recent dividend hike payable Feb. 11.

Sentiment:

🌋Volatile

Investment Analysis

Nucor

NUE

Pros

Nucor delivered a strong earnings beat in Q3 2025, with EPS of $2.63 surpassing expectations by 18.47%.
The company maintains robust financial health, with solid profitability and cash flow management ratings.
Nucor benefits from strategic investments and leadership in custom-engineered building products, supporting resilience in key markets.

Considerations

Nucor anticipates lower earnings in Q4 2025 due to seasonal factors, which may affect near-term performance.
The company's return on equity is below several industry peers, indicating less efficient capital use.
Nucor's stock exhibits higher volatility than the market average, increasing risk for conservative investors.

DuPont

DD

Pros

DuPont maintains a diversified portfolio across specialty chemicals, materials, and biotechnology sectors.
The company has a strong global presence and long-standing brand reputation in industrial markets.
DuPont's recent strategic initiatives focus on innovation and operational efficiency to drive future growth.

Considerations

DuPont reported a negative return on equity in recent periods, reflecting challenges in profitability.
The company faces ongoing regulatory and litigation risks related to legacy environmental liabilities.
DuPont's stock performance has been volatile, with a significant decline from its 52-week high, raising concerns about near-term stability.

Related Market Insights

American Auto Revival: Stellantis's $10B Manufacturing Gamble

Stellantis's massive $10 billion commitment to US manufacturing could trigger a supply chain renaissance, creating opportunities across domestic auto suppliers and industrial partners.